---
figid: PMC6772062__FEB2-593-1654-g001
figtitle: Canonical Wnt/B‐catenin and divergent signaling pathways
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC6772062
filename: FEB2-593-1654-g001.jpg
figlink: /pmc/articles/PMC6772062/figure/feb213502-fig-0001/
number: F1
caption: Canonical Wnt/β‐catenin and divergent signaling pathways. The binding of
  a Wnt ligand to a Frizzled receptor and LRP5/6 co‐receptor, followed by the recruitment
  of DVL to the receptor complex, leads to translocation and inhibition of the destruction
  complex, which consists of the kinase GSK3α/β, Adenomatous Polyposis Coli (APC)
  and Axin. The phosphorylation of β‐catenin by GSK3α/β in the active destruction
  complex primes this protein for proteasomal degradation (not shown). Upon inhibition
  of the complex, β‐catenin accumulates in the cytoplasm and translocates into the
  nucleus where it activates gene transcription as a co‐activator of LEF1/TCFs. This
  canonical pathway can branch downstream (a) GSK3α/β inhibition (e.g., to slow protein
  degradation during mitosis, activate the mTOR pathway, or stabilize the cytoskeleton),
  (b) β‐catenin stabilization (e.g., to stabilize cell adhesion with cadherins or
  facilitate the assembly of PDZ domain‐containing proteins), and (c) β‐catenin nuclear
  translocation (to activate gene transcription by interacting with nuclear receptors,
  FOXO and other transcription factors).
papertitle: 'Wnt/β‐catenin signaling in brain development and mental disorders: keeping
  TCF7L2 in mind.'
reftext: Joanna Bem, et al. FEBS Lett. 2019 Jul;593(13):1654-1674.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.935023
figid_alias: PMC6772062__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
redirect_from: /figures/PMC6772062__F1
ndex: 7d6f7452-df08-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6772062__FEB2-593-1654-g001.html
  '@type': Dataset
  description: Canonical Wnt/β‐catenin and divergent signaling pathways. The binding
    of a Wnt ligand to a Frizzled receptor and LRP5/6 co‐receptor, followed by the
    recruitment of DVL to the receptor complex, leads to translocation and inhibition
    of the destruction complex, which consists of the kinase GSK3α/β, Adenomatous
    Polyposis Coli (APC) and Axin. The phosphorylation of β‐catenin by GSK3α/β in
    the active destruction complex primes this protein for proteasomal degradation
    (not shown). Upon inhibition of the complex, β‐catenin accumulates in the cytoplasm
    and translocates into the nucleus where it activates gene transcription as a co‐activator
    of LEF1/TCFs. This canonical pathway can branch downstream (a) GSK3α/β inhibition
    (e.g., to slow protein degradation during mitosis, activate the mTOR pathway,
    or stabilize the cytoskeleton), (b) β‐catenin stabilization (e.g., to stabilize
    cell adhesion with cadherins or facilitate the assembly of PDZ domain‐containing
    proteins), and (c) β‐catenin nuclear translocation (to activate gene transcription
    by interacting with nuclear receptors, FOXO and other transcription factors).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP6
  - LRP5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3B
  - GSK3A
  - MTOR
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - CTNNB1
  - HNF4A
  - LEF1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - Lrp6
  - Lrp5
  - Dvl1
  - Apc
  - Axin1
  - Gm12892
  - Gsk3b
  - Gsk3a
  - Mtor
  - Ctnnb1
  - Lef1
  - lrp6
  - lrp5
  - apc
  - gsk3ba
  - gsk3ab
  - mtor
  - ctnnb1
  - elk4
  - lef1
  - Cancer
---
